Bio

Alexa Belonick is a corporate and securities lawyer who focuses on public companies representation, governance and capital markets transactions. She works with clients preparing to go public and through the full scope of post-IPO matters, including public and private debt and equity financings and ongoing public reporting and compliance. She works with leading technology and life sciences clients across industries including software, healthtech, fintech, medical devices, agtech, and consumer products. She has led at-the-market equity offerings, Rule 144A convertible debt offerings, secondary offerings, registered and privately placed equity and warrant offerings, and putting up shelf and resale registration statements. She also assists clients with an array of securities law structures for strategic transactions and mergers and acquisitions, including representing public companies being sold or acquiring other public companies in transactions that have a total deal value of over $18.5 billion. Alexa also advises companies including their management teams and boards of directors throughout the year on a range of securities regulation and corporate governance topics. She works with companies on compliance with NYSE and Nasdaq listing standards, Sarbanes Oxley, Dodd Frank, and U.S. federal securities laws. She also regularly works with companies on ’34 Act disclosure questions, responding to SEC comment letters, ESG initiatives, fine-tuning corporate governance policies and procedures, and Section 16 topics.